Clinical Trial Update: A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL) [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing Iodine-131 labeled anti-B1 antibody to unlabeled anti-B1 antibody in chemotherapy-relapsed/refractory low-grade or transfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma
• Transformed Low-grade Non-hodgkin Lymphoma

Drugs mentioned

• Anti-b1 antibody (anti-b1 monoclonal antibody)
• Iodine-131 anti-B1 antibody (iodine-131 labeled anti-B1 antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2012-10-05